查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1942762

2026年全球药物筛检市场报告

Drug Screening Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，药物筛检市场发展迅速，预计将从2025年的97.2亿美元成长到2026年的111.8亿美元，复合年增长率达15.0%。过去几年的成长可归因于职场药物检测项目的增加、临床试验活动的扩展、执法机关筛检要求的提高、诊断检查室的增长以及快速检测套组的日益普及。

预计未来几年，药物筛检市场规模将快速成长，到2030年将达到192亿美元，复合年增长率（CAGR）为14.5%。预测期内的成长可归因于人工智慧驱动的筛检分析技术的日益普及、携带式药物检测设备需求的增长、监管药物合规性检测的扩展、即时报告系统的广泛应用以及多组药物筛检的创新。预测期内的关键趋势包括快速药物检测套组的日益普及、自动化检查室筛检系统的使用日益增多、数位化报告解决方案的日益整合、照护现场药物检测的扩展以及对高精度检测的日益重视。

药物筛检市场的成长预计将受到毒品和酒精消费量不断上升趋势的推动。药物成瘾是一种影响大脑和行为的疾病，会导致人们不受控制地使用合法和非法物质，例如酒精、大麻和尼古丁。随着药物和酒精成瘾的加剧，相关的健康风险也随之增加，这必然会催生对药物筛检的需求。例如，根据联合国毒品犯罪防制署（UNODC）于2025年6月发布的报告，到2023年，将有3.16亿人使用毒品（不包括酒精和烟草），占15至64岁人口的6%。大麻仍然是使用最广泛的毒品，使用者达2.44亿，其次是阿片类药物（6100万）、安非他命（3070万）、可卡因（2500万）和摇头丸（2100万）。报导警告称，逃离困境、动盪和衝突的新弱势群体可能会进一步推高这些数字。持续的新冠疫情进一步加剧了毒品风险，某些地区年轻人的大麻消费量增加了近四倍。毒品和酒精消费量的上升是推动药物筛检市场成长的主要因素。

在药物筛检市场中营运的公司越来越重视策略伙伴关係和合作，以增强其财务基础、拓展产品线并扩大地域覆盖范围。策略联盟是指两个或多个独立组织之间达成的协议，旨在共同追求既定目标，同时维持营运自主性。例如，2025年2月，加拿大药物检测公司Neopharma Technologies和美国认知评估公司Impairment Science宣布建立策略联盟，以推动药物和认知障碍检测技术的发展。此次合作将整合Neopharma的NEOVAULT平台（该平台可对快速药物检测结果进行数位分析与报告）与Impairment Science的DRUID认知障碍评估系统（一款基于人工智慧的认知障碍评估工具）。透过结合这些技术，此次合作旨在提供关于药物检测和认知障碍的即时洞察，从而提高药物筛检的准确性和实用性。这项措施可望透过人工智慧和数位化报告解决方案，改善职场安全、支援合规性，并提升安全关键环境中的决策水准。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球药物筛检市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 人工智慧（AI）和自主人工智慧
    • 工业4.0和智慧製造
    • 数位化、云端运算、巨量资料、网路安全
    • 物联网、智慧基础设施和互联生态系统
    • 生物技术、基因组学和精准医学
  • 主要趋势
    • 扩大快速药物检测套组的引入
    • 扩大自动化检测系统的应用
    • 数位化报告解决方案的整合度不断提高
    • 扩大照护现场药物检测
    • 人们越来越关注高精度检测

第五章 终端用户产业市场分析

  • 药物检测实验室
  • 职场
  • 医院
  • 执法机关
  • 药物治疗中心

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球药物筛检市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球药物筛检市场规模、对比及成长率分析
  • 全球药物筛检市场表现：规模与成长，2020-2025年
  • 全球药物筛检市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 副产品
  • 快速检测设备、耗材及其他产品
  • 依检体类型
  • 口腔液样本、毛髮样本、尿液样本、呼气样本和其他样本类型
  • 最终用户
  • 药物检测实验室、职场、刑事司法和执法机关、医院、戒毒中心、个人药物使用者、疼痛管理中心、学校和学院
  • 按类型细分：快速检测设备
  • 尿液药物检测套组、唾液药物检测套组、血液药物检测仪、即时检测试纸
  • 按类型细分：消耗品
  • 试剂及检测方法、检体采集检体、校正标准品
  • 按类型细分：其他产品
  • 实验室设备、软体解决方案、储存和运输解决方案

第十章 区域与国家分析

  • 全球药物筛检市场：依地区、绩效及预测划分，2020-2025年、2025-2030年预测、2035年预测
  • 全球药物筛检市场：依国家、绩效及预测划分，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第三十六章：竞争格局与公司概况

  • 药物筛检市场：竞争格局及市场占有率（2024年）
  • 药物筛检市场：公司估值矩阵
  • 药物筛检市场：公司概况
    • Laboratory Corporation
    • Quest Diagnostics Incorporated
    • OraSure Technologies Inc.
    • Alfa Scientific Designs Inc.
    • Abbott Laboratories

第37章：其他领先和创新企业

  • Thermo Fisher Scientific Inc., Dragerwerk AG & Co. KGaA, LifeLoc Technologies Inc., MPD Inc., Omega Laboratories Inc., Premier Biotech Inc., Psychemedics Corporation, F. Hoffmann-La Roche Ltd., Shimadzu Corporation, Siemens Healthineers AG, Medtox Scientific Inc., American Screening Corporation, Clinical Reference Laboratory Inc., Express Diagnostics International Inc., Global Drug Testing Services

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年药物筛检市场：提供新机会的国家
  • 2030年药物筛检市场：充满新机会的细分领域
  • 2030年药物筛检市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME3MDSCR01_G26Q1

Drug screening is an approach used for drug testing, specifically designed and optimized for clinical trials. It involves the analysis of blood, urine, hair, or saliva to detect the presence of chemicals, pollutants, and other illicit substances left in the body due to drug usage.

The main types of drug screening products include rapid testing devices, consumables, and other related items. Rapid testing devices are user-friendly screening tools that provide quicker results compared to traditional laboratory tests. Various samples, such as oral fluid, hair, urine, breath, and others, are used in drug screening. These screenings find applications in drug testing laboratories, workplaces, criminal justice and law enforcement, hospitals, drug treatment centers, individual users, pain management centers, schools, and colleges.

Tariffs are impacting the drug screening market by increasing costs of imported reagents, assay kits, analytical instruments, sensors, and laboratory equipment. Diagnostic laboratories and law enforcement agencies in North America and Europe are most affected due to reliance on imported consumables, while Asia-Pacific faces cost pressure on test kit manufacturing. These tariffs are raising testing costs and procurement challenges. However, they are also encouraging domestic reagent production, localized kit assembly, and innovation in cost-efficient drug screening solutions.

The drug screening market research report is one of a series of new reports from The Business Research Company that provides drug screening market statistics, including drug screening industry global market size, regional shares, competitors with a drug screening market share, detailed drug screening market segments, market trends and opportunities, and any further data you may need to thrive in the drug screening industry. This drug screening market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug screening market size has grown rapidly in recent years. It will grow from $9.72 billion in 2025 to $11.18 billion in 2026 at a compound annual growth rate (CAGR) of 15.0%. The growth in the historic period can be attributed to increasing workplace drug testing programs, expansion of clinical trial activities, rising law enforcement screening requirements, growth of diagnostic laboratories, wider availability of rapid test kits.

The drug screening market size is expected to see rapid growth in the next few years. It will grow to $19.2 billion in 2030 at a compound annual growth rate (CAGR) of 14.5%. The growth in the forecast period can be attributed to increasing adoption of ai-enabled screening analytics, rising demand for portable drug testing devices, expansion of regulatory drug compliance testing, growing use of real-time reporting systems, innovation in multi-panel drug screening. Major trends in the forecast period include increasing adoption of rapid drug testing kits, rising use of automated laboratory screening systems, growing integration of digital reporting solutions, expansion of point-of-care drug testing, enhanced focus on high-accuracy detection.

The growth of the drug screening market is expected to be driven by the increasing prevalence of drug and alcohol consumption. Drug addiction, a condition affecting both brain and behavior, leads to the inability to control the use of legal or illegal substances such as alcohol, marijuana, and nicotine. As drug and alcohol addiction rise, the associated health risks also increase, necessitating the demand for drug screening. IFor instance, in June 2025, According to the United Nations Office on Drugs and Crime, a Austria based United Nations office, reported 316 million people used a drug (excluding alcohol and tobacco) in 2023, or six per cent of the population aged between 15 and 64,. With 244 million users, cannabis remains the most widely used drug, followed by opioids (61 million), amphetamines (30.7 million), cocaine (25 million) and "ecstasy" (21 million). New groups of vulnerable people fleeing hardship, instability and conflict could cause these numbers to increase further, the report warns. The ongoing pandemic further exacerbated drug risks, with youth cannabis intake increasing up to four times in certain regions. The escalating drug and alcohol consumption significantly contribute to the growth of the drug screening market.

Companies operating in the drug screening market are increasingly emphasizing strategic partnerships and collaborations to strengthen financial capabilities, enhance product offerings, and expand geographic reach. A strategic collaboration involves an agreement between two or more independent organizations to jointly pursue defined objectives while maintaining operational autonomy. For example, in February 2025, Neopharma Technologies, a Canada-based drug testing company, and Impairment Science, a U.S.-based cognitive assessment company, announced a strategic partnership focused on advancing drug and impairment testing. The collaboration integrates Neopharma's NEOVAULT platform, which digitally interprets and reports rapid drug test results, with Impairment Science's DRUID cognitive impairment assessment, an AI-enabled tool designed to evaluate functional impairment. By combining these technologies, the partnership seeks to improve the precision and practical relevance of drug screening by delivering real-time insights into both substance detection and functional impairment. This initiative has the potential to enhance workplace safety, support regulatory compliance, and improve decision-making in safety-sensitive environments through the use of AI and digital reporting solutions.

In June 2024, Premier Biotech, a U.S.-based provider of urine and oral fluid drug testing solutions and toxicology services, acquired Desert Tox, LLC for an undisclosed amount. Through this acquisition, Premier Biotech seeks to expand its laboratory testing capabilities, reinforce its position in the oral-fluid drug testing market, and extend its national customer reach across workplace, government, and occupational health segments. Desert Tox, LLC is a U.S.-based company that delivers SAMHSA-certified urine and oral-fluid drug testing services to employment, government, and clinical clients.

Major companies operating in the drug screening market are Laboratory Corporation, Quest Diagnostics Incorporated, OraSure Technologies Inc., Alfa Scientific Designs Inc., Abbott Laboratories, Thermo Fisher Scientific Inc., Dragerwerk AG & Co. KGaA, LifeLoc Technologies Inc., MPD Inc., Omega Laboratories Inc., Premier Biotech Inc., Psychemedics Corporation, F. Hoffmann-La Roche Ltd., Shimadzu Corporation, Siemens Healthineers AG, Medtox Scientific Inc., American Screening Corporation, Clinical Reference Laboratory Inc., Express Diagnostics International Inc., Global Drug Testing Services, Kroll Laboratory Specialists Inc., Medscreen Laboratories, National Screening Centers Inc., American Bio Medica Corporation, Mayo Clinic Laboratories, ACM Global Laboratories, Intertek Group plc, Eurofins Scientific SE

North America was the largest region in the drug screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the drug screening market during the forecast period. The regions covered in the drug screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the drug screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The drug screening market consists of sales of testing kits, reagents, and other supplies. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug Screening Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses drug screening market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug screening ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The drug screening market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Products: Rapid Testing Devices; Consumables; Other Products
  • 2) By Sample Type: Oral Fluid Sample; Hair Sample; Urine Sample; Breath Sample; Other Sample Types
  • 3) By End User: Drug Testing Laboratories; Workplaces; Criminal Justice and Law Enforcement Agencies; Hospitals; Drug Treatment Centers; Individual Users; Pain Management Centers; Schools and Colleges
  • Subsegments:
  • 1) By Rapid Testing Devices: Urine Drug Test Kits; Saliva Drug Test Kits; Blood Drug Test Devices; Instant Test Strips
  • 2) By Consumables: Reagents and Assays; Sample Collection Devices; Calibration Standards
  • 3) By Other Products: Laboratory Equipment; Software Solutions; Storage and Transport Solutions
  • Companies Mentioned: Laboratory Corporation; Quest Diagnostics Incorporated; OraSure Technologies Inc.; Alfa Scientific Designs Inc.; Abbott Laboratories; Thermo Fisher Scientific Inc.; Dragerwerk AG & Co. KGaA; LifeLoc Technologies Inc.; MPD Inc.; Omega Laboratories Inc.; Premier Biotech Inc.; Psychemedics Corporation; F. Hoffmann-La Roche Ltd.; Shimadzu Corporation; Siemens Healthineers AG; Medtox Scientific Inc.; American Screening Corporation; Clinical Reference Laboratory Inc.; Express Diagnostics International Inc.; Global Drug Testing Services; Kroll Laboratory Specialists Inc.; Medscreen Laboratories; National Screening Centers Inc.; American Bio Medica Corporation; Mayo Clinic Laboratories; ACM Global Laboratories; Intertek Group plc; Eurofins Scientific SE
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Drug Screening Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Drug Screening Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Drug Screening Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Drug Screening Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Industry 4.0 & Intelligent Manufacturing
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Biotechnology, Genomics & Precision Medicine
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Rapid Drug Testing Kits
    • 4.2.2 Rising Use Of Automated Laboratory Screening Systems
    • 4.2.3 Growing Integration Of Digital Reporting Solutions
    • 4.2.4 Expansion Of Point-Of-Care Drug Testing
    • 4.2.5 Enhanced Focus On High-Accuracy Detection

5. Drug Screening Market Analysis Of End Use Industries

  • 5.1 Drug Testing Laboratories
  • 5.2 Workplaces
  • 5.3 Hospitals
  • 5.4 Law Enforcement Agencies
  • 5.5 Drug Treatment Centers

6. Drug Screening Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Drug Screening Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Drug Screening PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Drug Screening Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Drug Screening Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Drug Screening Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Drug Screening Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Drug Screening Market Segmentation

  • 9.1. Global Drug Screening Market, Segmentation By Products, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Rapid Testing Devices, Consumables, Other Products
  • 9.2. Global Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Oral Fluid Sample, Hair Sample, Urine Sample, Breath Sample, Other Sample Types
  • 9.3. Global Drug Screening Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Drug Testing Laboratories, Workplaces, Criminal Justice and Law Enforcement Agencies, Hospitals, Drug Treatment Centers, Individual Users, Pain Management Centers, Schools and Colleges
  • 9.4. Global Drug Screening Market, Sub-Segmentation Of Rapid Testing Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Urine Drug Test Kits, Saliva Drug Test Kits, Blood Drug Test Devices, Instant Test Strips
  • 9.5. Global Drug Screening Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Reagents and Assays, Sample Collection Devices, Calibration Standards
  • 9.6. Global Drug Screening Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Laboratory Equipment, Software Solutions, Storage and Transport Solutions

10. Drug Screening Market Regional And Country Analysis

  • 10.1. Global Drug Screening Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Drug Screening Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Drug Screening Market

  • 11.1. Asia-Pacific Drug Screening Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Drug Screening Market, Segmentation By Products, Segmentation By Sample Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Drug Screening Market

  • 12.1. China Drug Screening Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Drug Screening Market, Segmentation By Products, Segmentation By Sample Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Drug Screening Market

  • 13.1. India Drug Screening Market, Segmentation By Products, Segmentation By Sample Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Drug Screening Market

  • 14.1. Japan Drug Screening Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Drug Screening Market, Segmentation By Products, Segmentation By Sample Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Drug Screening Market

  • 15.1. Australia Drug Screening Market, Segmentation By Products, Segmentation By Sample Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Drug Screening Market

  • 16.1. Indonesia Drug Screening Market, Segmentation By Products, Segmentation By Sample Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Drug Screening Market

  • 17.1. South Korea Drug Screening Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Drug Screening Market, Segmentation By Products, Segmentation By Sample Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Drug Screening Market

  • 18.1. Taiwan Drug Screening Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Drug Screening Market, Segmentation By Products, Segmentation By Sample Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Drug Screening Market

  • 19.1. South East Asia Drug Screening Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Drug Screening Market, Segmentation By Products, Segmentation By Sample Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Drug Screening Market

  • 20.1. Western Europe Drug Screening Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Drug Screening Market, Segmentation By Products, Segmentation By Sample Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Drug Screening Market

  • 21.1. UK Drug Screening Market, Segmentation By Products, Segmentation By Sample Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Drug Screening Market

  • 22.1. Germany Drug Screening Market, Segmentation By Products, Segmentation By Sample Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Drug Screening Market

  • 23.1. France Drug Screening Market, Segmentation By Products, Segmentation By Sample Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Drug Screening Market

  • 24.1. Italy Drug Screening Market, Segmentation By Products, Segmentation By Sample Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Drug Screening Market

  • 25.1. Spain Drug Screening Market, Segmentation By Products, Segmentation By Sample Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Drug Screening Market

  • 26.1. Eastern Europe Drug Screening Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Drug Screening Market, Segmentation By Products, Segmentation By Sample Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Drug Screening Market

  • 27.1. Russia Drug Screening Market, Segmentation By Products, Segmentation By Sample Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Drug Screening Market

  • 28.1. North America Drug Screening Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Drug Screening Market, Segmentation By Products, Segmentation By Sample Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Drug Screening Market

  • 29.1. USA Drug Screening Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Drug Screening Market, Segmentation By Products, Segmentation By Sample Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Drug Screening Market

  • 30.1. Canada Drug Screening Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Drug Screening Market, Segmentation By Products, Segmentation By Sample Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Drug Screening Market

  • 31.1. South America Drug Screening Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Drug Screening Market, Segmentation By Products, Segmentation By Sample Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Drug Screening Market

  • 32.1. Brazil Drug Screening Market, Segmentation By Products, Segmentation By Sample Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Drug Screening Market

  • 33.1. Middle East Drug Screening Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Drug Screening Market, Segmentation By Products, Segmentation By Sample Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Drug Screening Market

  • 34.1. Africa Drug Screening Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Drug Screening Market, Segmentation By Products, Segmentation By Sample Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Drug Screening Market Regulatory and Investment Landscape

36. Drug Screening Market Competitive Landscape And Company Profiles

  • 36.1. Drug Screening Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Drug Screening Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Drug Screening Market Company Profiles
    • 36.3.1. Laboratory Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. OraSure Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Alfa Scientific Designs Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

37. Drug Screening Market Other Major And Innovative Companies

  • Thermo Fisher Scientific Inc., Dragerwerk AG & Co. KGaA, LifeLoc Technologies Inc., MPD Inc., Omega Laboratories Inc., Premier Biotech Inc., Psychemedics Corporation, F. Hoffmann-La Roche Ltd., Shimadzu Corporation, Siemens Healthineers AG, Medtox Scientific Inc., American Screening Corporation, Clinical Reference Laboratory Inc., Express Diagnostics International Inc., Global Drug Testing Services

38. Global Drug Screening Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Drug Screening Market

40. Drug Screening Market High Potential Countries, Segments and Strategies

  • 40.1 Drug Screening Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Drug Screening Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Drug Screening Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer